(Q31126371)

29 June 2017

title

Vasoactive intestinal peptide binding autoantibodies in autoimmune humans and mice (English)

1 reference

29 June 2017

1 reference

Yogesh Bangale

1

1 reference

29 June 2017

Dana Cavill

2

1 reference

29 June 2017

Tom Gordon

3

1 reference

29 June 2017

Stephanie Planque

4

1 reference

29 June 2017

Hiroaki Taguchi

5

1 reference

29 June 2017

Gita Bhatia

6

1 reference

29 June 2017

Yasuhiro Nishiyama

7

1 reference

29 June 2017

Frank Arnett

8

1 reference

29 June 2017

Sudhir Paul

9

1 reference

29 June 2017

language of work or name

1 reference

1 December 2002

1 reference

29 June 2017

number of pages

7

1 reference

inferred from page(s)

published in

Peptides

1 reference

29 June 2017

volume

23

1 reference

29 June 2017

issue

12

1 reference

29 June 2017

page(s)

2251-2257

1 reference

Cloning and expression of an autoimmune DNA-binding single chain Fv. Only the heavy chain is required for binding.

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

New evidence for transmitter role of VIP in the airways: impaired relaxation by a catalytic antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Development of systemic lupus erythematosus in mice is associated with alteration of neuropeptide concentrations in inflamed kidneys and immunoregulatory organs.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Vasoactive intestinal peptide mediation of development and functions of T lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Original and artificial antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Enhancement by vasoactive intestinal peptide of gamma-interferon production by antigen-stimulated type 1 helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Spontaneous hydrolysis of vasoactive intestinal peptide in neutral aqueous solution.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Human autoantibody to vasoactive intestinal peptide: increased incidence in muscular exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Characterization of autoantibodies to vasoactive intestinal peptide in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Phosphonate ester probes for proteolytic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Influence of neuropeptides on airway smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Genetics of systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2802%2900265-6

7 January 2021

10.1016/S0196-9781(02)00265-6

Identifiers

DOI

1 reference

29 June 2017

1 reference